Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML - Risueño, A; See, WL; Bluemmert, I; de Botton, S; DiNardo, CD; Fathi, AT; Schuh, AC; Montesinos, P; Vyas, P; Prebet, T; Gandhi, A; Hasan, M (Leukemia Research, 2024)